Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02838251
Other study ID # ULCERE MIXTE
Secondary ID
Status Completed
Phase N/A
First received July 13, 2016
Last updated July 26, 2016
Start date September 2015
Est. completion date July 2016

Study information

Verified date July 2016
Source Groupe Hospitalier Paris Saint Joseph
Contact n/a
Is FDA regulated No
Health authority France: Ministry of HealthFRANCE: Committee for the protection of Persons
Study type Observational

Clinical Trial Summary

About 15% to 30% of patients with venous leg ulcers have a peripheral arterial disease (PAD) associated. The compression band is still a controversial issue in this context. It allows the reduction of venous hypertension and edema, but it could potentially degrade the arterial infusion of high levels of compression. The French High Authority for Health (HAS) defines mixed ulcers by IPS between 0.5 and 0.9. Investigators distinguish mixed ulcers blood predominance for IPS between 0.5 and 0.7; and mixed ulcers predominantly venous blood with moderate involvement for IPS values between 0.7 and 0.9.

Several studies have shown that IPS> 0.8 allowed a high compression, between 30 and 40 mmHg. In the case of mixed ulcers with IPS between 0.6 and 0.8, the HAS recommends using a lighter compression, bit by elastic bands (exercising low power compression at rest) under medical supervision, informing the patient to remove the bandage if pain or aggravation. It is therefore necessary to adapt the compression therapy in case of venous ulcers associated with arterial disease by providing a lower compression 30 mmHg short stretch. For HAS, IPS <0.6 against indicates compression.

A recent study showed that compression bit elastic bands could not only improve venous return, but it would also increase the distal arterial flow in a patient population with mixed ulcers. In this study, 25 patients had between IPS 0.5 and 0.8; or for certain patients below the threshold of 0.6 indicates that against a compression according to HAS. To our knowledge this is the only study that has examined the effect of compression on blood perfusion.


Description:

Objectives:

- Principal: Study the distal arterial infusion in a patient population with mixed ulcers under compression leg with little elastic bands

- Secondary: To evaluate the safety of the little compression elastic band in a mixed population of patients with leg ulcers

Methodology :

- Study non-interventional prospective single-center that evaluates professional practice from 25 patients with mixed leg ulcers and followed in the vascular medicine department of St. Joseph Hospital Group Paris.

- Applying a bit compression elastic bandages to a pressure level between 30 and 40mmHg.

- Anonymous data reports on the grid standardized collection, by a numbering system from 1 to 30 and then captured on a computer file

- Age, risk factors and cardiovascular history of the patients,

- Age, ulcer description

- Palpation of pulse

- morphological vascular profile of patients with arterial and venous Doppler dating less than a year,

- Series following data before installation, 10 minutes after application and 24 hours after installation of the inelastic compression:

o Evaluation of tolerance:

- measurement of pain numeric scale (NS)

- description of the skin condition of the leg by a dermatologist, seeking signs of suffering skin after application of compression: possible appearance of erythema, cyanosis, purpura. A search particularly in areas of bony prominences and the banks of the ulcer.

o distal arterial pressures of the compression carrier leg:

- IPS (systolic pressure index): ankle and arm pressures will be measured with a cuff and a continuous Doppler. GPI is calculated by dividing the lowest pressure at the ankle (at the dorsalis pedis or posterior tibial artery) by the humeral pressure.

- Transcutaneous Oxygen Pressure (TcPO2) o Measuring pressure exerted by low elastic bandages by Kikuhime® system.

In case of bad tolerance of compression at any time after installation, the compression will be removed and the study stopped for the patient in question. Poor tolerance is defined by an increase in pain than or equal to 2 points on the digital scale.

expected benefits for patients:

- Demonstration of good tolerance, defined as no worsening of the skin condition and the lack of increase in pain associated with inelastic compression.

- Demonstration of no worsening of arterial infusion by inelastic compression.

- Evidence of improved distal arterial hemodynamics (increased IPS and tcpO2) with a little elastic compression, which validate the results of the only study ever conducted on the subject.


Recruitment information / eligibility

Status Completed
Enrollment 25
Est. completion date July 2016
Est. primary completion date July 2016
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility The mixed origin of the ulcer is defined by a venous disease (reflux in the superficial veins and / or deep) and a moderate arterial disease, defined by:

Inclusion Criteria:

- A IPS 0.5 and 0.9, with a systolic pressure at the ankle> 70 mmHg

- A big toe pressure index (IPGO) <0.7, with a systolic pressure of the big toe (PGO)> 50 mmHg

Exclusion Criteria:

- Topics aged under 18,

- A normal IPS that is to say between 0.9 and 1.3, a critical ischemia (defined as ankle pressure <70 mmHg and / or systolic pressure of the big toe <50 mmHg)

- Presence of peripheral neuropathy,

- Presence of heart failure,

- Refusal to participate in the study or to sign the consent,

- Impaired cognitive function not to participate in a clinical study.

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Other:
No intervention


Locations

Country Name City State
France Groupe Hospitalier Paris Saint Joseph Paris Ile-de-France

Sponsors (1)

Lead Sponsor Collaborator
Groupe Hospitalier Paris Saint Joseph

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Assessment of change of pain numeric scale Day 1, just before the exam, 10minutes after the exam and 24 hours after the exam No
Secondary Assessment of change of distal arterial pressures of the compression carrier leg Day 1, just before the exam, 10minutes after the exam and 24 hours after the exam No
Secondary Assessment of change of IPS (systolic pressure index) ankle pressures Day 1, just before the exam, 10minutes after the exam and 24 hours after the exam No
Secondary Assessment of change of pressure exerted by low elastic bandage Measuring pressure exerted by low elastic bandages by Kikuhime® system. Day 1, just before the exam, 10minutes after the exam and 24 hours after the exam No
Secondary Assessment of IPS (systolic pressure index) arm pressures Day 1, just before the exam, 10minutes after the exam and 24 hours after the exam No
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT02565264 - Effect of Plasma Derived Exosomes on Cutaneous Wound Healing Early Phase 1
Recruiting NCT00926809 - H. Pylori Eradication on Healing of Iatrogenic Gastric Ulcer by Endoscopic Mucosal Resection Phase 4
Completed NCT00633035 - Comparison of Esomeprazole and Famotidine for Stress Ulcer Prophylaxis in Neurosurgical Intensive Care Unit Phase 4
Completed NCT00402727 - Comparison of Sequential IV/PO Moxifloxacin With IV Piperacillin/Tazobactam Followed by PO Amoxicillin/Clavulanic Acid in Patients With a Complicated Skin and Skin Structure Infection Phase 3
Completed NCT06464250 - The Effect of Bundle Approach on Foot Care Behaviors and Diabetic Wound Healing in Patients N/A
Not yet recruiting NCT03250533 - Analysis of the Effects of LED Phototherapy and Electrical Stimulation in the Healing of Diabetic Ulcers N/A
Terminated NCT01657318 - Olivamine-containing Products in the Management of Patients With Nonhealing Lower Extremity Ulcers
Completed NCT02535481 - Epidermal Grafting in Wound Healing N/A
Withdrawn NCT01215058 - Gastroprotective Agent Compliance in Patients at Risk Suffering From a Gastrointestinal(GI) Ulcer N/A
Recruiting NCT04210089 - Total Contact Soft Cast in Diabetic Foot Ulcers N/A
Completed NCT04573959 - Validation of CapsoVision CapsoCam® SV-3 Capsule Endoscopy System N/A
Recruiting NCT03347812 - Clinical Study for Evaluating the Safety and Efficacy of Total Endovascular Aortic Arch Repair N/A
Active, not recruiting NCT02973893 - Study of VF001-DP in Patients With Chronic Venous Leg Ulcers Phase 2
Terminated NCT01853384 - Safety and Efficacy Trial of HP802-247 in the Treatment of Chronic Venous Leg Ulcers Phase 3
Completed NCT00221143 - Stem Cell Study for Patients With Leg Ulcer/Gangrene Phase 1/Phase 2
Completed NCT00158483 - Anti-Herpetic Treatment of Genital Ulcer : Effect on HIV & Herpes Shedding (ANRS 1212) Phase 2
Completed NCT00660049 - Feasibility Study of a Novel Device for Chronic Wounds N/A
Completed NCT00450216 - Efficacy and Safety Study of HZT-501 in Subjects Requiring Nonsteroidal Anti-Inflammatory Drug (NSAID) Treatment Phase 3
Completed NCT00164424 - Episodic Acyclovir Therapy for Genital Ulcers Phase 2/Phase 3
Completed NCT02733978 - Ozone Therapy in the Treatment of Digital Ulcers in Patients With Systemic Sclerosis N/A